VALERIANI NICHOLAS J 4

What Happened Nicholas J. Valeriani, a director of Edwards Lifesciences (EW), received a grant of 5,127 restricted stock units (RSUs) on May 8, 2026. The Form 4 reports the acquisition price as $0.00 because these are compensatory RSUs (not an open‑market purchase); no immediate cash value or sale was reported on the filing. This is a director compensation award rather than a buy or sell that signals trading sentiment.

Key Details

• Transaction date: May 8, 2026; price reported: $0.00 per unit.
• Grant size: 5,127 restricted stock units.
• Shares owned after transaction: not specified on the filing (the Form 4 states it reflects changes in beneficial ownership only).
• Footnote: RSUs were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and are scheduled to become 100% vested upon the earlier of one year from the grant date or the issuer's next annual meeting of stockholders.
• Filing timeliness: Form 4 filed for the period ending May 8, 2026 (transaction and filing date match), indicating a timely report.

Context RSUs are a form of equity compensation that convert to actual shares only when they vest; they are not an immediate cash purchase or sale. Director grants like this are common for nonemployee directors and are intended as compensation for service rather than a directional bet on the stock. The Form 4’s remark notes it reflects only this change in beneficial ownership and may not list other securities the reporting person holds.